Markets
Hands of an elderly man typing on laptop with data and graphs of stock market on the screen. Business analysis and statistic. Keyboard close up.  Neural network, future technologies
Getty Images
Weird Money

Welcome to the era of stock-picking AI chatbots

An Israeli startup just received approval for a chatbot that will pick stocks. Would you take its advice?

Jack Raines

If you ask ChatGPT, “Which stocks should I buy,” the chatbot will reply with something like “I'm unable to provide specific stock recommendations as I'm not a licensed financial advisor.” (This is a verbatim response from my ChatGPT, I’m guessing you’ll receive something similar).

However, a Tel-Aviv-based startup just received approval from the Israel Securities Authority to release a chatbot designed to answer this very question, and later this month, users will be able to solicit the hottest stock picks from their digital aid. From Bloomberg:

Tel Aviv-based Bridgewise has been given the green light by the Israel Securities Authority (ISA) to release a chatbot called Bridget later this month that can offer recommendations for which stocks to buy and sell in response to user queries. The startup is working with one of the country’s largest banks, Israel Discount Bank, to roll out the product…

A spokesperson for the Israeli regulator said the approval came with restrictions. The tool cannot include advice “that is specific to the user,” for example, or have a conversation that appears to be “personal advice.”

When testing the chatbot, its responses included a disclaimer about the service’s limitations. “The information is not tailored to you specifically and is not a substitute for personal investment advice,” the disclaimer said.

I love everything about this. First, the point that Bridget can provide stock picks, but it can’t include advice “that is specific to the user” is just great. If something is considered a good stock pick for one person, wouldn’t that make it a good stock pick for everyone? If Bridget tells me that Cloudflare is a good investment for XYZ reason, wouldn’t that same reason apply to any other investor? If it’s a good investment, it’s a good investment. Period.

This disclaimer reminds me of when I see folks promoting different stock picks on X or Substack, before including a parenthetical phrase that says, “Not financial advice!” Like, that’s great, but it’s not actually a legal defense. I imagine that we’re around two months away from a headline that says “Investor sues Bridgewise after stock pick recommendation drops 20% in one week.”

That being said, I do think a stock picking tool like this, if its recommendations aren’t taken at face value, will be a valuable tool for investors that expedites research. According to the Bloomberg report, Bridget provides reasons for its buy and sell recommendations, allowing investors to more quickly find relevant data on different companies from which they can draw their own conclusions.

I will be interested to check back in a couple of years and see how a fully Bridget-recommended portfolio performs compared to the S&P 500.

More Markets

See all Markets
markets

Health insurance stocks lose steam as Trump says he’ll lobby insurers for lower prices

Shares of health insurance companies dropped Friday afternoon, as President Trump said he would ask insurers to meet with him in the coming weeks to seek lower prices.

Stocks including Humana, UnitedHealthcare, Cigna, CVS Health, and Elevance Health all either pared gains or went further into the red after Trump’s remarks, which came at the end of a press event to announce pricing deals with nine drugmakers.

“I’m going to call a meeting of the big insurance companies that have gotten so rich,” Trump said, noting that he would lobby them for lower prices.

“I would say that maybe with one talk, they would be willing to cut their prices by 50, 60, or 70%. They’ve made a fortune.”

markets

Rivian’s surge continues as stock reaches highest level since December 2023 on analyst upgrades

Shares of EV maker Rivian are on pace to close up double digits for the second day in a row on Friday as bullish investors pour into the stock following analyst upgrades.

Rivian shares were up more than 10% on Friday afternoon, with the stock climbing to its highest level since December 2023.

Webush’s Dan Ives boosted his Rivian price target by 56% to $25 in a note on Friday morning. The analyst wrote that 2026 is a “prove-me” year for the automaker, with its lower-cost R2 model set to launch in the first half.

Ives’s note follows a separate optimistic bit of analysis from Baird, which also boosted its Rivian price target to $25 in a note on Thursday.

If today's gains hold, Friday will mark the third day of double-digit gains for Rivian in the past six trading days. An “AI Day” event that saw the automaker detail autonomous updates and tease a robotaxi plan started the recent run.

markets

The neoclouds are shooting back up into the stratosphere

Investors’ faith in tech CEOs’ pursuit of digital God has seemingly been restored for now, sparking an intense rally in the speculative AI players that had been in full-on meltdown mode over concerns that the boom had passed its best-before date.

The data center companies colloquially known as the “neoclouds” — CoreWeave, Nebius, IREN, and Cipher Mining — are up more than double digits over the past two sessions, as of 10:40 a.m. ET.

The past 48 hours have brought a steady drumbeat of positive news for the AI theme.

CoreWeave received a vote of confidence from Wall Street as Citi resumed coverage with a buy rating and price target of $135. Oracle, the epicenter of AI credit concerns, has seen a reversal in its fortunes as it nears an acquisition of TikTok’s US operations. And OpenAI’s fundraising efforts appear be going so well that its reported valuation has gone up in back-to-back days.

Before that, Micron’s earnings reaffirmed the intense demand for AI compute, which continues to outstrip supply — a positive sign for the neoclouds. The macro backdrop is also turning perhaps a bit more in favor of lower interest rates, as CPI inflation came in well below expectations.

Snoop Dogg Performs At OVO Hydro Glasgow

Marijuana rescheduling could mean more investment in US weed stocks. There aren’t many ways in.

“Yes, institutional capital will go into the underlying names. The question is: How fast?" one weed company chairman said.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.